ACCESS Act of 2017 Accessible Care by Curbing Excessive lawSuitS Act of 2017 [HB-1704]
ACCESS Act of 2017 Accessible Care by Curbing Excessive lawSuitS Act of 2017 This bill establishes provisions governing health care lawsuits where coverage for the care was provided or subsidized by the federal government. The bill does not preempt certain state laws and federal vaccine injury laws and rules. The statute of limitations is three years after the injury or one year after the claimant discovers the injury, whichever occurs first, with exceptions. Noneconomic damages are limited to $250,000. Juries may not be informed of this limitation.
(continued...)
HB-1704: ACCESS Act of 2017 Accessible Care by Curbing Excessive lawSuitS Act of 2017
Sponsored by: Rep. Lloyd Smucker
Referred To The Subcommittee On The Constitution And Civil Justice. on 04/06/2017
HR-215: Expressing the fact that the House of Representatives supports the system for prescription drug coverage provided under part D of the Medicare program and believes that changes to such system should not be part of the American Health Care Act of 2017.
Sponsored by: Rep. Gus Bilirakis
Referred To The Subcommittee On Health. on 03/24/2017
You have voted HR-215: Expressing the fact that the House of Representatives supports the system for prescription drug coverage provided under part D of the Medicare program and believes that changes to such system should not be part of the American Health Care Act of 2017..
American Health Care Act of 2017 [HB-1628]
American Health Care Act of 2017 TITLE I--ENERGY AND COMMERCE Subtitle A--Patient Access to Public Health Programs (Sec. 101) This bill amends the Patient Protection and Affordable Care Act (PPACA) to eliminate funding after FY2018 for the Prevention and Public Health Fund, which provides for investment in prevention and public health programs to improve health and restrain the rate of growth in health care costs. Funds that are unobligated at the end of FY2018 are rescinded. (Sec. 102) The bill amends the Medicare Access and CHIP Reauthorization
(continued...)
HB-1628: American Health Care Act of 2017
Sponsored by: Rep. Diane Black
Returned To The Calendar. Calendar No. 120. on 07/28/2017
TARGET Act Targeted Rewards for the Global Eradication of Human Trafficking [HB-1625]
TARGET Act Targeted Rewards for the Global Eradication of Human Trafficking (Sec. 2) This bill expresses the sense of Congress that the Department of State's rewards program is a powerful tool in combating sophisticated international crime and that the State Department and federal law enforcement should work in concert to offer rewards that target human traffickers who prey on the most vulnerable people around the world. (Sec. 3) The State Department Basic Authorities Act of 1956 is amended to include severe forms of trafficking in persons involving
(continued...)
HB-1625: TARGET Act Targeted Rewards for the Global Eradication of Human Trafficking
Sponsored by: Rep. Ted Poe
Became Public Law No: 115-141. on 03/23/2018
VA Prescription Data Accountability Act 2017 [HB-1545]
VA Prescription Data Accountability Act 2017 (Sec. 2) This bill directs the Department of Veterans Affairs (VA) to disclose information about an individual who is dispensed medication prescribed by a VA employee or by a non-VA provider authorized to prescribe such medication by the VA (currently, about a veteran or the dependent of a veteran) to a state controlled substance monitoring program to the extent necessary to prevent misuse and diversion of prescription medicines.
HB-1545: VA Prescription Data Accountability Act 2017
Sponsored by: Rep. Ryan Costello
Became Public Law No: 115-86. (txt | Pdf) on 11/21/2017
Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017 [S.637]
Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017 This bill amends title XI (General Provisions) of the Social Security Act (SSAct) to require the public disclosure of certain information provided to the Department of Health and Human Services (HHS) by a pharmacy benefit manager (PBM) that contracts with: (1) a prescription drug plan (PDP) under Medicare or Medicare Advantage (MA), or (2) a qualified health benefits plan offered through an exchange established under the Patient Protection and Affordable Care Act. Specifically,
(continued...)
S.637: Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017
Sponsored by: Sen. Ron Wyden
Read Twice And Referred To The Committee On Finance. on 03/15/2017
Safe and Affordable Drugs from Canada Act of 2017 [HB-1480]
Safe and Affordable Drugs from Canada Act of 2017 This bill amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to require the Department of Health and Human Services (HHS) to promulgate regulations within 180 days permitting individuals to import a prescription drug purchased from an approved Canadian pharmacy that: is dispensed by a pharmacist licensed in Canada; is purchased for personal use in quantities not greater than a 90-day supply; is filled using a valid prescription issued by a physician licensed to practice in the United States;
(continued...)
HB-1480: Safe and Affordable Drugs from Canada Act of 2017
Sponsored by: Rep. Steve Cohen
Referred To The Subcommittee On Health. on 03/10/2017
To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. [HB-1436]
To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017. This bill amends the Patient Protection and Affordable Care Act (PPACA) to terminate the Prevention and Public Health Fund. The bill increases funding for community health centers. The Department of Health and Human Services may not collect fees or make payments under the transitional reinsurance program. The bill makes appropriations for grants to states to address substance abuse or urgent mental health needs. This bill amends the
(continued...)
HB-1436: To provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017.
Sponsored by: Rep. Luke Messer
Referred To The Subcommittee On Health. on 03/10/2017
A bill to provide for reconciliation pursuant to section 2002 of the concurrent resolution on the budget for fiscal year 2017. [S.554]
A bill to provide for reconciliation pursuant to section 2002 of the concurrent resolution on the budget for fiscal year 2017. This bill amends the Patient Protection and Affordable Care Act (PPACA) to terminate the Prevention and Public Health Fund. The bill increases funding for community health centers. The Department of Health and Human Services may not make payments under the transitional reinsurance program. The bill makes appropriations for grants to states to address substance abuse or urgent mental health needs. This bill amends the Internal
(continued...)
S.554: A bill to provide for reconciliation pursuant to section 2002 of the concurrent resolution on the budget for fiscal year 2017.
Sponsored by: Sen. Mike Lee
Read Twice And Referred To The Committee On Finance. on 03/07/2017
Prescriber Support Act of 2017 [HB-1375]
Prescriber Support Act of 2017 This bill amends the Public Health Service Act to authorize the Department of Health and Human Services (HHS) to award grants to states for systems that help prescribers: (1) treat and manage patient pain; and (2) prevent, identify, and respond to patient substance misuse and substance abuse disorders. In awarding grants, HHS must give priority to states with the greatest need.
HB-1375: Prescriber Support Act of 2017
Sponsored by: Rep. James Langevin
Referred To The Subcommittee On Health. on 03/17/2017
Cancer Drug Parity Act of 2017 [HB-1409]
Cancer Drug Parity Act of 2017 This bill amends the Public Health Service Act to require group and individual health plans that cover anticancer medications administered by a health care provider to provide no less favorable cost sharing for patient-administered anticancer medications. This requirement applies to medication approved by the Food and Drug Administration that is prescribed based on a finding by the treating physician that the medication is medically necessary for cancer treatment and is clinically appropriate in terms of type, frequency,
(continued...)
HB-1409: Cancer Drug Parity Act of 2017
Sponsored by: Rep. Ted Poe
Referred To The Subcommittee On Health. on 03/17/2017
Medical Innovation Prize Fund Act [S.495]
Medical Innovation Prize Fund Act This bill denies any person the exclusive right to manufacture, distribute, sell, or use a drug, a biological product, or a medication manufacturing process. The bill establishes the Fund for Medical Innovation Prizes to provide for prize payments in lieu of market exclusivity. The Board of Trustees of the fund must award prize payments to: (1) the first person to receive approval for a medication; (2) the holder of the patent for a manufacturing process; and (3) persons or communities that contributed to the development
(continued...)
S.495: Medical Innovation Prize Fund Act
Sponsored by: Sen. Bernard Sanders
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 03/02/2017
Prescription Drug Price Transparency Act [HB-1316]
Prescription Drug Price Transparency Act This bill adds certain transparency requirements for pharmacy benefits managers under Medicare, Medicare Advantage, TRICARE, and the Federal Employees Health Benefits Program.
HB-1316: Prescription Drug Price Transparency Act
Sponsored by: Rep. James Langevin
Referred To The Subcommittee On Military Personnel. on 04/05/2017